In-house Discovery

In addition to its serviced-based operation, Prosarix is using the ProtoDiscovery™ platform to develop a limited number of lead series against specific GPCR targets which have application in the CNS field.

Prosarix's most advanced program has recently shown pre-clinical efficacy in models of pain, anxiety and depression.

Please contact Prosarix for further information/register your interest:


©Prosarix 2007-19 ¦ Newton Hall, Town Street, Newton, Cambridge, CB22 7ZE ¦ +44 (0)1223 870400 ¦ ¦ legal